Echosens
Jean-Baptiste Thumerel has a diverse work experience spanning several companies and roles. Jean-Baptiste is currently working at Echosens as the Medical Devices Software Director. Prior to this, they spent over a decade at GE Healthcare, where they held several positions including Director of Software Engineering, Program Manager, Staff Technical Project Manager, and Software Projects Leader. Jean-Baptiste also worked at iXblue as a Software Project Leader and at Nexter Systems, MBDA, France Telecom, and Mappy as a Software Engineer. Throughout their career, Jean-Baptiste has demonstrated strong leadership skills, managing teams, and overseeing various projects. Jean-Baptiste has experience in software development, project management, and operational management.
Jean-Baptiste Thumerel pursued their education in a dedicated manner, as demonstrated by their diverse education history. In 2000, they enrolled at ECE. Ecole d'ingénieurs. Engineering School, where they completed their Master's degree in Computer Science in 2005. This laid the foundation for their future academic pursuits. Subsequently, in 2004, they attended Staffordshire University, where they pursued a Master's degree in Computer Science, completing it in 2005. Following this, in 2008, Jean-Baptiste Thumerel attended the prestigious Université Paris-Sorbonne, earning a Master of Business Administration (M.B.A.) degree. Through these educational experiences, they honed their skills and developed a strong academic background in both computer science and business administration.
Echosens
1 followers
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 4,200+ peer-reviewed publications and 180+ international guidelines recommendations. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide. We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH. As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.